Director at Delcath (NASDAQ: DCTH) awarded 22,500 stock options

Rhea-AI Filing Summary

DELCATH SYSTEMS, INC. director Steven A. J. Salamon received a grant of stock options covering 22,500 shares of common stock. The options have an exercise price of $11.61 per share and represent a compensation-related award, not an open-market purchase.

The options vest in equal monthly installments of one-twelfth of the grant, starting on May 13, 2026, as long as he continues serving as a director under the company’s 2020 Omnibus Equity Incentive Plan. The options expire 10 years from the grant date or, for vested portions, two years after his last day of service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SALAMON STEVEN A J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	22,500	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 22,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 22,500 options Exercise price: $11.61 per share Underlying shares: 22,500 shares +5 more

8 metrics

Options granted 22,500 options Stock Option (right to buy) grant to director

Exercise price $11.61 per share Exercise price for the stock options

Underlying shares 22,500 shares Common stock underlying the option grant

Post-transaction options held 22,500 options Total options reported following this grant

Vesting start date May 13, 2026 First monthly vesting date for the options

Vesting rate 1/12 per month Monthly vesting schedule while serving as director

Maximum option term 10 years Outside limit from grant date before expiration

Post-service exercise window 2 years For vested options after last day of service

Key Terms

Stock Option (right to buy), vesting, 2020 Omnibus Equity Incentive Plan, exercise price

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

vesting financial

"The option will vest and become exercisable at the rate of one-twelfth"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

2020 Omnibus Equity Incentive Plan financial

"subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan"

exercise price financial

"conversion_or_exercise_price: 11.6100"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SALAMON STEVEN A J

(Last) (First) (Middle)

15 WELLESLEY STREET WEST, SUITE 326

(Street)

TORONTO M4Y 0G7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
DELCATH SYSTEMS, INC. [ DCTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.61	05/13/2026		A		22,500		(1)	(1)	Common Stock	22,500	$0	22,500	D

Explanation of Responses:

1. The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.

	/s/ Gerard Michel, Attorney-in-Fact	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DELCATH SYSTEMS (DCTH) report on this Form 4?

DELCATH SYSTEMS reported a director receiving 22,500 stock options as a compensation grant. These options give the right to buy common shares at a fixed price and do not involve any open-market buying or selling of existing stock.

How many DELCATH SYSTEMS (DCTH) options were granted to the director?

The director was granted stock options on 22,500 underlying shares of DELCATH common stock. This entire amount is a new award and represents his total option holdings reported following this transaction in the Form 4 data.

What is the exercise price of the new DELCATH SYSTEMS (DCTH) stock options?

The granted stock options have an exercise price of $11.61 per share. This means the director can purchase DELCATH common stock at $11.61 once the options vest, regardless of the future market price.

When do the DELCATH SYSTEMS (DCTH) options granted to the director vest?

The options vest in monthly installments of one-twelfth of the grant, beginning May 13, 2026. Vesting continues each month as long as the individual remains a director and is subject to the company’s 2020 Omnibus Equity Incentive Plan.

What is the expiration policy for the new DELCATH SYSTEMS (DCTH) stock options?

The options expire the earlier of 10 years from the grant date or, for vested options, two years after the director’s last day of service. After expiration, any unexercised options can no longer be used to purchase shares.

Is the DELCATH SYSTEMS (DCTH) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant of stock options as compensation, not a market trade. The director did not buy or sell shares on the open market; he received options that may be exercised in the future after vesting.